LOLS10在线直播下注

九州ku游娱乐appShape 大富贵彩票官网Shape 大富豪电玩author 万博体育官网Shape 搜狐彩票游戏chevron 千亿国际投注cross ku体育博彩Shape 恒峰彩票平台Shape 新利18投注Shape 澳门萄京AⅤGroup 老虎机漏洞公布hamburger 牛牛登录home 拉菲用户注册Group 28元体验金magnify 甘肃体彩平台Shape 经典牛牛开户Shape 牛牛下载Shape 牛牛开户注册rss SUNBET平台Shape

A novel way of assessing broodstock value

3 August 2020, at 8:12am

Assessing the value of a company’s broodstock is now possible, following the launch of a new service from Xelect.

Xelect are able to put a value on a company's broodstock
Xelect are able to put a value on a company's broodstock

For decades, aquaculture mergers and acquisitions have focused on the financial and infrastructure aspects of a transaction. Until now there’s been no clear way to evaluate what lies at the heart of a company’s value: its broodstock.

In recent years our industry has grown and evolved, and the value of transactions has increased significantly. Investors and potential owners have been looking for a way to get confidence in the quality and sustainability of a company’s biological capital. , a Scottish independent aquaculture genetics expert, has long been trusted by some of the biggest names in the industry to manage and increase the value of their broodstock.

The team’s new BioAudit combines specialist genetics skills with deep industry know-how to provide independent and confidential genetic audits, alongside biological due diligence. This unique service will give investors and buyers a wealth of new insights to help them make more informed decisions.

Recent examples of BioAudit projects by Xelect include:

  • Advising the sovereign wealth fund of a prominent Middle Eastern country
  • A high profile due diligence project for a major sea bass and sea bream transaction.

Xelect’s CEO, Professor Ian Johnston, commented: “Every BioAudit project we do is completely bespoke for the client, but it typically includes a site visit, interviews with key personnel and a detailed genetic analysis of the broodstock at our custom-built laboratory. Customers get a detailed report and presentation, highlighting any risks from inbreeding or past genetic management, and an assessment of whether there is sufficient genetic diversity for selective breeding to improve key commercial traits – all key factors for the future sustainability and profitability of the business.”

Operations director, Dr Tom Ashton, adds: “The team here are truly unique, with a highly specialised set of skills and backgrounds. This means that, as well as a genetics audit, we can offer a wide-ranging biological due diligence service, covering feasibility of production targets, a biosecurity review, environmental and animal welfare checks and analysis of harvesting and processing practices. We think it’s quite a game changer for M&A ”.